Tuberculosis (TB) & our Lung Health Solutions
Tuberculosis (TB) is a serious health problem worldwide, causing 1.3 million deaths in 2022. It can be even more harmful than HIV. TB is most common in places like Southeast Asia, Africa, and the Western Pacific, making it a big challenge for health.
At Delft Imaging, we understand the importance of finding good ways to detect and manage TB, Silicosis, and general lung health. We’ve worked hard to create advanced solutions for lung health that make TB screening better. When you explore our Lung Health solutions, you’ll find new tools and technologies that change how we deal with TB and lung health. We aim to create a world where the impact of TB, Silicosis, and other lung health issues on people is significantly reduced.
Delft Imaging believes that every man, woman
and child should benefit from advances in healthcare
– regardless of where they live.
About Delft Imaging
At Delft Imaging, we dream of a world where healthcare is a universal right, not a privilege. Through our reliable, cost-effective diagnostic imaging solutions and AI software, we’re driving global health transformations, aiming for a universally healthier future with each innovation.

Innovative Solutions

High-Quality Imaging and Safety

Full After-Service Support

Local Partnerships
